Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Artyom A. Basov has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysis of Epidemiological Features of Pertussis Caused by Bordetella parapertussis

    by O. Yu. Borisova, A. S. Pimenova, I. Yu. Andrievskaya, M. S. Petrova, A. A. Basov, N. S. Bashketova, I. S. Kataeva, A. V. Mironova, D. D. Fedorov, O. I. Selin, et al.

    Relevance . Many countries in the world with high coverage of preventive vaccinations have seen an increase in the incidence of pertussis since the 1980s. The sharpest rise in the incidence of pertussis in the world has been recorded since 2023–2024. In recent years, the number of cases of pertussis caused by B. parapertussis has been increasing, which may be due to vaccination pressure, lack of cross-immunity, as well as the widespread use of PCR diagnostics. B. parapertussis does not produce pertussis toxin, but it is characterized by virulence factors similar to B. pertussis. Aims . To show the role of B. parapertussis in the epidemiology of pertussis and to analyze the clinical and epidemiological features of a pertussis outbreak caused by B. parapertussis. Material and methods. The study includes official statistical data and analytical materials obtained as part of the work of the Reference Center for Pertussis Monitoring of the G. N. Gabrichevsky Research Institute of Epidemiology and Microbiology, Rospotrebnadzor, as well as maps of the epidemiological examination of the focus, medical documentation for patients and laboratory tests. The PCR study was carried out using two sets of reagents AmpliSence Bordetella multi-FL (FBUN TsNIIE, Russia) and AmpliPrime Bordetella (NecstBio LLC, Russia). Statistical data processing was performed using Microsoft Excel 2019. Results . The incidence of whooping cough caused by B. parapertussis in the Russian Federation over the past 10 years does not exceed 2.0 per 100 thousand population. Among the sick, the proportion of children 0-17 years old was at the level of 88.8 % – 98.8 %. The highest age indicator was in children under 1 year old in 2016–2021 and 2023–2024 and children 3–6 years old in 2022 and 2025. The largest number of cases is recorded in children 7–14 years old. In 2025, the number of cases in children 3-6 years old increased sharply. In 2025, 186,005 studies for pertussis were performed in the Russian Federation with a predominance of using PCR diagnostics (55.5 %). During the period of rising incidence (2019 and 2023), B. pertussis dominates the structure of pathogens and since 2025 the share of B. parapertussis circulation has increased to 30 %, including by epidemiological indications to 40.0 %. As an example of an epidemiological examination, a description of an acute focus with multiple cases of the disease in a preschool institution is given. Conclusion . Whooping cough caused by B. parapertussis is reported annually and predominantly in children. An increase in the specific gravity of B. parapertussis among pertussis pathogens was shown against the background of a decrease in the incidence in 2024–2025. The analysis of the focus revealed the predominance of an erased course (in four children) and bacteriocarrier (in three children), and also confirmed the high diagnostic efficiency of PCR when examining foci of pertussis.

  • Open Access

    The increase in the Incidence of Haemophilus influenzae infection against the Background of Immunization in the Russian Federation in 2019 –2025

    by S. O. Vysochanskaya, A. A. Basov, K. A. Yatskovsky, A. V. Sulima, С. О. Высочанская, А. А. Басов, К. А. Яцковский, А. В. Сулима

    Background . Haemophilus influenzae infection remains a significant cause of infectious morbidity in the Russian Federation, particularly among the pediatric population. Aim . To characterize the features of the epidemic process of Haemophilus influenzae infection in 2019–2025 and to substantiate directions for optimizing surveillance measures. Materials and Methods. Data were collected using specially designed tables that included information on vaccination history, age structure, clinical forms, social groups of cases, diagnostic methods, and serotyping results. Based on the information obtained, a retrospective epidemiological analysis was performed. The study covered the period from 2019 to 2025. To assess morbidity dynamics and preventive vaccination coverage, monthly and annual statistical reporting Forms No. 2 ("Data on Infectious and Parasitic Diseases") and annual Forms No. 6 ("Data on Populations of Children and Adults Vaccinated Against Infectious Diseases") for the specified period were used [30, 32]. To study population immunity to Haemophilus influenzae infection, serological testing of blood serum samples was performed. Results and Discussion. It was established that, despite achieving a high level of vaccination coverage against Hib infection in the pediatric population (over 95%), a steady increase in morbidity has been observed in 2022–2025: in 2025, it reached 4.25 per 100,000 population, exceeding the long-term average level by a factor of 19.3. A shift in morbidity toward older age groups (50–65 years) was revealed, along with a change in the clinical structure characterized by a predominance of pneumonia (up to 94.5%) and the registration of fatal outcomes among the adult population. At the same time, against the background of routine immunization of children in the first years of life against serotype b, initiated in 2022 within the National Calendar of Preventive Vaccinations, the proportion of purulent bacterial meningitis (PBM), which had previously reached 20% among the clinical forms of Haemophilus influenzae infection, decreased to 1.5% over the past three years. The current surveillance system does not provide for serotyping of H. influenzae strains, which makes it impossible to conduct full-scale epidemiological surveillance of this infection. The results of serological analysis confirm extensive circulation of the pathogen in the population. Conclusion . The increase in the incidence of Haemophilus influenzae infection is presumably attributable to the loss of natural population immunity resulting from social distancing measures during the COVID-19 pandemic; to an increase in registered morbidity due to the introduction of highly sensitive PCR systems; and to the biological process of serotype replacement, whereby non-vaccine H. influenzae strains have come to occupy a dominant position in the etiological structure. At the same time, the high level of coverage and timeliness of vaccination of children in the first years of life against Hib infection made it possible to reduce the proportion of invasive forms of the disease caused by this pathogen. Priority directions for the development of epidemiological surveillance include the introduction of PCR panels for pathogen detection, standardization of serotyping methods, and the establishment of serological monitoring of postvaccination immunity. In addition, it is advisable to consider revaccination against Hib infection for persons in risk groups, including those over 50 years of age.

  • Open Access

    Assessment of the prevention of secondary spread of whooping cough in clusters of group morbidity

    by A. A. Basov, O. V. Tsvirkun, O. Yu. Borisova, T. R. Belova, S. O. Vysochanskaya, K. A. Yatskovsky, V. R. Saifutdinova, E. V. Baydakova

    Relevance. Secondary spread of pertussis in schools is driven by waning immunity by the age of 6–7 years, low clinical vigilance among healthcare workers regarding pertussis in over 5 years old, and close contact within organized groups. The scope and quality of anti-epidemic measures play a key role in the rapid containment of infection outbreaks. Aims. To evaluate the effectiveness of anti-epidemic measures in cluster outbreaks of pertussis in schools across several regions of the Russian Federation. Materials and Methods . Data from 36 geographically and temporally unlinked cluster outbreaks of pertussis across 9 regions of the Russian Federation in 2023 (the period of the highest incidence peak in 26 years) were analyzed. Standard reporting forms and custom-developed evaluation tables were utilized, capturing parameters such as outbreak duration, number of cases and contacts, laboratory testing coverage, and the timing and scope of implemented interventions (including the transition to remote learning). Results. The mean duration of outbreak monitoring was 41 days (range: 21 to 88 days). In all outbreaks, anti-epidemic measures (isolation, medical surveillance, and room ventilation) were implemented promptly. The transition to remote learning was implemented in 14 outbreaks. A positive correlation was found between the number of cases and both the number of classes switched to remote learning (rs = 0.63, p < 0.001) and the timing of this transition (rs = 0.53, p = 0.001). This indicates that remote learning was resorted to out of necessity in large, prolonged outbreaks, when standard containment measures had already failed to yield results. Conclusions . The prolonged duration and scale of outbreaks indicate a lack of immune protection among schoolchildren. Transitioning to remote learning is effective as an anti-epidemic measure only during the early stages of an outbreak. Monitoring and validation of clear criteria for evaluating the effectiveness of anti-epidemic measures in pertussis outbreaks are required. Medical surveillance and laboratory testing of exposed individuals are critical for the early detection of cases and their prompt removal from the school setting.

  • Acute Flaccid Paralysis in a Vaccinated Child With Primary Immunodeficiency: Difficulties With Diagnostics of Vaccine‐Associated Paralytic Poliomyelitis

    by Armen K. Shakaryan, Yulia M. Mikhailova, Alina V. Chirova, Evgeniya A. Cherepanova, Olga Y. Baikova, Elizaveta V. Yakovchuk, Evgenia V. Karpova, Aleksander P. Ivanov, Svetlana V. Skryabina, Tatiana E. Snitkovskaya, et al.

    Oral polio vaccine (OPV) from attenuated Sabin strains widely used for poliomyelitis prevention and eradication along with undeniable advantages has significant disadvantages, one of which is the ability to cause cases of vaccine‐associated paralytic poliomyelitis (VAPP). Inactivated poliovirus vaccine (IPV) introduction into the national immunization schedules of countries that continue to use OPV allows effective prevention of VAPP cases and simultaneously forms immunity to PV type 2. The present study presents an example of VAPP development in a child with Bruton's disease, born by in vitro fertilization, vaccinated with four IPV doses followed by one bOPV dose, and paralysis onset 52 days bOPV vaccination. Despite objective clinical, laboratory and instrumental signs of anterior corneal myelitis, the isolation of Sabin‐like poliovirus, and contradictory results of serological investigation, diagnostics caused significant difficulties for the treating physicians. The case was associated with a recombinant poliovirus of vaccine Sabin strains types 3 and 1 with a recombination point in 2C‐encoding genome region, containing known neurovirulence reverse mutations and some unique ones. The introduction of IPV doses for primary immunization increases the safety of immunization against polio; however, while OPV is in use there is still a VAPP threat for immunocompromised children and unvaccinated contacts.


  • Epidemic Process of Haemophilus influenzae Infection in WHO Regions

    by S. O. Vysokochanskaya, S. Y. Kombarova, R. V. Polibin, A. A. Basov

    Relevance. Although the incidence of Hib infection has decreased in the last three decades, it is still significant. Even with appropriate treatment, the case-fatality rate can be as high as 5%. Up to 40% of children with infection may suffer lifelong complications. Although Hib infection is classified as vaccine-preventable, WHO and CDC do not post annual incidence information on their resources, unlike other vaccine-preventable infections. Therefore, an assessment of the global epidemic situation can only be based on the results of studies conducted in different countries.Objective. To assess the incidence of Haemophilus influenzae type b infection in selected countries of the world and the Russian Federation against the background of the introduction of specific vaccine prophylaxis.Conclusion. The incidence of invasive Hib infection in countries where vaccination against this infection is unavailable or has only recently been included in national vaccination programmes depends on maintaining high vaccination coverage and well-functioning surveillance systems. The persistently low incidence in all countries that have introduced Hib vaccine illustrates the success of routine vaccination programmes in providing effective protection to vaccinees and promoting collective immunity. However, the continued detection of cases of invasive forms of Haemophilus influenzae infection raises concerns that other serotypes may be displaced if mass immunisation with serotype b vaccine is carried out globally.


  • Open Access

    Microbicides for Topical HIV Immunoprophylaxis: Current Status and Future Prospects

    by Yury V. Zhernov, Vladislava O. Petrova, Mark Y. Simanduyev, Denis V. Shcherbakov, Roman V. Polibin, Oleg V. Mitrokhin, Artem A. Basov, Nadezhda N. Zabroda, Sonya O. Vysochanskaya, Ezzulddin Al-Khaleefa, et al.

    Microbicides, which are classified as topical antiseptic agents, are a revolutionary advancement in HIV prevention aimed to prevent the entry of infectious agents into the human body, thus stopping the sexual transmission of HIV and other sexually transmitted diseases. Microbicides represent the promise of a new age in preventive measures against one of the world’s most pressing health challenges. In addition to their direct antiviral effects during HIV transmission, microbicides also influence vaginal mucosal immunity. This article reviews microbicides by presenting different drug classifications and highlighting significant representatives from each group. It also explains their mechanisms of action and presents information about vaginal mucosal immune responses, emphasizing the critical role they play in responding to HIV during sexual transmission. The article discusses the following groups of microbicides: surfactants or membrane disruptors, vaginal milieu protectors, anionic polymers, dendrimers, carbohydrate-binding proteins, HIV replication inhibitors (reverse transcriptase inhibitors), and multi-purpose prevention technologies, which combine protection against HIV, other sexually transmitted diseases, and contraception. For each chemical compound, the article provides a brief overview of relevant preclinical and clinical research, emphasizing their potential as microbicides. The article offers insights into the multifaceted impact of microbicides, which signify a pivotal step forward in the pursuit of effective and accessible pre-exposure prophylaxis (PrEP).


  • Open Access

    Criteria for Assessing the Epidemiological Situation of Pertussis in Russian Federation

    by A. A. Basov, S. O. Vysochanskaya, O. V. Tsvirkun, T. R. Belova, S. E. Aduguzelov, Yu. V. Zhernov, K. A. Yatskovsky

    Relevance. Differences in case definition criteria and diagnostic recommendations of pertussis between different countries, pose challenges in the analysis and effective control of disease. An important component of successful surveillance is laboratory diagnostics, which, if used in a timely and quality manner, can influence the rate of reported cases. In addition, current criteria for epidemiological surveillance do not sufficiently take into account the severity of the disease and the vaccination status of the patient, which makes it difficult to take effective preventive measures. Aims. Assess the epidemiological situation regarding pertussis infection in Russia to propose criteria for epidemiological surveillance. Materials and methods. The data was obtained from official state statistics (form No. 2 «Information on infectious and parasitic diseases», No. 5 «Information on preventive vaccinations», No. 6 «Information on the contingents of children and adults vaccinated against infectious diseases») and analytical tables developed at G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology, including information on each case of pertussis and collected from the Rospotrebnadzor Directorates in the Russian Federation (in 2017–2022). Statistical data processing and plotting were carried out with R version 4.1.2. Results. From 2002 to 2017, the incidence of pertussis in Russia did not exceed the established norms. However, in 2019 there was an increase in incidence. In 2023, the incidence of pertussis reached record levels over the past 22 years – 19.0 per 100 thousand population. Vaccination rates against pertussis have remained high since 2003. The structure of cases shows that the majority of pertussis cases occur among unvaccinated children in the first year of life; deaths from pertussis are recorded annually, mainly among unvaccinated children under 2 years of age. From 2017 to 2019, the incidence among the unvaccinated was significantly higher than among the vaccinated; in 2020-2022, incidence among the unvaccinated decreased, but remained higher than among the vaccinated during the period of COVID-19 restrictive measures. There was no statistically significant difference in the distribution of pertussis severity in the periods before and after the COVID19 pandemic. Outbreaks of infection are mostly without spread, and in 2020-2022 the proportion of such outbreaks has increased. Schools remain the main site of infection, but the proportion of cases in kindergartens has increased. Conclusions. The following criteria for epidemiological well-being are proposed: subject to the achievement of timely vaccination coverage in 95% of people of decreed ages and timely implementation of anti-epidemic measures, there should be no deaths from pertussis, the incidence of pertussis should be sporadic and registered predominantly (more than 50% of cases) in the form of mild forms, the majority of pertussis cases occur among unvaccinated children in the first year of life (no more than 30% of vaccinated cases) and outbreaks without the spread of infection should prevail (more than 50% of cases) over outbreaks with spread.


  • Open Access

    Assessment of the State of Antidiphtheria Immunity in Different Age Groups of the Population of the Russian Federation Based on Seromonitoring Data for 2015–2021

    by A. A. Basov, N. M. Maksimova, S. O. Vysochanskaya, O. V. Tsvirkun, K. A. Yatskovsky, S. E. Aduguzelov

    Relevance. Diphtheria is one of the dangerous diseases that threaten human life. Immunization is the only means of creating a favorable epidemiological situation. Ensuring the immunity of the population to this infection prevents the occurrence of the rise and spread of diphtheria among the population. One of the ways to assess the state of specific immunity to diphtheria is annual serological monitoring. Aims. Assessment of the state of antidiphtheria immunity in different age groups of the population of the Russian Federation based on seromonitoring data for 2015–2021. Materials and methods. The data of serological monitoring of diphtheria and the state of vaccination of the population by indicator groups from 85 subjects of the Russian Federation in 2015–2021 were analyzed. In just 7 years, in terms of seromonitoring in Russia, 439,874 people were examined for the presence of antibodies to diphtheria, including 73,559 children in the age group of 3–4 years, 74,424 adolescents aged 15–17 years, and 291,891 adults aged 18 and older. During the same period, 12,154 controlled blood sera from 20 subjects of the Russian Federation were examined. In the age group of 3–4 years – 1834 children, 15–17 years – 1366 teenagers, 18–29 years – 1711 adults, 30–39 years – 1724 adults, 40–49 years – 1918 adults, 50–59 years – 1798 adults, 60 years and older – 1803 adults. The presence of antibodies to diphtheria was determined in the course of passive hemagglutination. The protective titers of antibodies were taken to be dilution of sera with a titer of 1:20 or more, the intensity of anti-diphtheria immunity was assessed as follows: antibody titers in dilution of sera 1:20–1:40 – low titers, 1:80–1:160 – medium and 1:320 or more – high titers of antibodies of JSC «Biomed» im. I. I. Mechnikov. Results and discussion. In Russia, improving the surveillance system for diphtheria continues to be an urgent task of the private epidemiology of this infection. The data obtained during the study allowed us to characterize the population immunity of the population of the Russian Federation, as a whole across the country, as sufficient to prevent the occurrence and spread of diphtheria. The main factor contributing to this was the long-term high coverage of vaccinations against diphtheria of persons in the decreed age groups (more than 95% of those vaccinated from the number of persons to be vaccinated in each age group). When comparing the level of immunization of the population depending on age, it was found that the percentage of vaccinated persons in the age group of people 50 years and older was statistically significantly lower than in the group of people younger than 50 years. The data of serological studies in Russia as a whole showed a high proportion of people with protective titers of antibodies to diphtheria in each age group – 3–4 years – 96.7 ± 0.1%, 15–17 years – 98.3 ± 0.1%, 18–29 years – 96,0 ± 0,4% – 97,5 ± 0,3%, 30–39 – 95,9 ± 0,4% – 97,5 ± 0.3%, 40–49 years old – 95,7 ± 0,4% – 97,7 ± 0,3%. The largest proportion of seronegative individuals is detected among groups aged 50–59 years and 60 years and older. The analysis of the share of seronegative persons in certain subjects of the Russian Federation revealed that the number of territories with a share of seronegative persons of more than 10% in the age groups of 50–59 years and 60 years and older was significantly higher than in other age groups. Conclusion. Thus, when planning companies for «сatch-up» immunization, it is advisable to provide mandatory revaccination of seronegative persons over 50 years of age. Timely revaccination according to the National Vaccination Calendar, tracking the proportion of persons susceptible to diphtheria in all indicator groups, followed by revaccination of seronegative persons in older ages will allow maintaining a high level of population immunity (more than 95%) and ensuring a consistently low incidence of diphtheria in the country for many years.


  • Open Access

    Diphtheria, tetanus, and pertussis immunity among healthcare professionals and pregnant women in the Moscow region, Russian federation: A preliminary cross-sectional study

    by Artem A. Basov, Yury V. Zhernov, Maria I. Kashutina, Natalia N. Kashkovskaya, Svetlana Yu. Kombarova, Inga I. Enilenis, Lyudmila P. Severova, Inna A. Fadeeva, Sonya O. Vysochanskaya, Elena V. Belova, et al.

    Despite more than 50 years of primary immunization against diphtheria, pertussis, and tetanus in Russia, complicated illnesses, including fatal ones, still occur. The goal of this preliminary cross-sectional study is to see how well pregnant women and healthcare workers are protected against diphtheria, pertussis, and tetanus. The required sample size (pregnant women and healthcare professionals, as well as pregnant women of two age categories) for this preliminary cross-sectional study was calculated using a confidence value of 0.95 and a probability of 0.05. The required number of participants in each group calculated sample size must be at least 59 people. In the Moscow region (Solnechnogorsk city, Russia), a cross-sectional study of pregnant patients and healthcare professionals interacting with children regularly as part of their job from numerous medical organizations was conducted in the year 2021 (n = 655). Antibodies to diphtheria, tetanus, and pertussis toxoids and microorganisms were measured using an enzyme-linked immunosorbent assay (ELISA). The STATISTICA and IBM SPSS Statistics 26.0 were used to process the study results statistically. Descriptive statistics methods, the Mann–Whitney U-test, discriminant analysis with the stepwise selection and analysis of ROC-curves were applied. IgG against diphtheria was found in 99.5% of pregnant women, tetanus in 91.5%, and pertussis in only 36.5%. According to the results of the discriminant analysis, the value of IgG to pertussis is linked to the value of IgA to pertussis and the gestational periods. Immunity to diphtheria was discovered in 99.1% of medical personnel, tetanus in 96.9%, and pertussis in 43.9%, no significant variations with age. When comparing the levels of immunity of pregnant women and healthcare professionals, it was shown that healthcare workers have greater levels of immunity against diphtheria and tetanus. The novel contribution of this study is that it will reveal the proportion of those vulnerable to pertussis, diphtheria, and tetanus among health workers and pregnant women in all age groups under the current national immunization program in Russia. Considering the data obtained from the preliminary cross-sectional study, we believe that it is necessary to conduct a full-scale study on a larger sample and, based on that, make certain changes to the national immunization program in Russia.


  • Open Access

    The Role of Chloroviruses as Possible Infectious Agents for Human Health: Putative Mechanisms of ATCV-1 Infection and Potential Routes of Transmission

    by Yury V. Zhernov, Sonya O. Vysochanskaya, Artem A. Basov, Vitaly A. Sukhov, Anton A. Simanovsky, Inna A. Fadeeva, Roman V. Polibin, Ekaterina A. Sidorova, Denis V. Shcherbakov, Oleg V. Mitrokhin

    The Chlorovirus genus of the Phycodnaviridae family includes large viruses with a double-stranded DNA genome. Chloroviruses are widely distributed in freshwater bodies around the world and have been isolated from freshwater sources in Europe, Asia, Australia, and North and South America. One representative of chloroviruses is Acanthocystis turfacea chlorella virus 1 (ATCV-1), which is hosted by Chlorella heliozoae. A few publications in the last ten years about the potential effects of ATCV-1 on the human brain sparked interest among specialists in the field of human infectious pathology. The goal of our viewpoint was to compile the scant research on the effects of ATCV-1 on the human body, to demonstrate the role of chloroviruses as new possible infectious agents for human health, and to indicate potential routes of virus transmission. We believe that ATCV-1 transmission routes remain unexplored. We also question whether chlorella-based nutritional supplements are dangerous for ATCV-1 infections. Further research will help to identify the routes of infection, the cell types in which ATCV-1 can persist, and the pathological mechanisms of the virus’s effect on the human body.